Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (4): 345-352.doi: 10.3969/j.issn.1000-6621.2020.04.009
• Original Articles • Previous Articles Next Articles
QIN Nan,XU Chun-ze,GUAN Ying,LU Li-ping,WANG Wei-bing(),JIANG Yong-gen()
Received:
2019-11-27
Online:
2020-04-10
Published:
2020-04-07
Contact:
Wei-bing WANG,Yong-gen JIANG
E-mail:wwb@fudan.edu.cn;877162034@qq.com
QIN Nan,XU Chun-ze,GUAN Ying,LU Li-ping,WANG Wei-bing,JIANG Yong-gen. The characteristics and analysis of influencing factors of tuberculosis registered dead patients in Songjiang City, Shanghai[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 345-352. doi: 10.3969/j.issn.1000-6621.2020.04.009
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.04.009
特征 | 观察 例数 | 平均随访 时间(年) | 全死因死亡 | 因结核死亡 | ||||
---|---|---|---|---|---|---|---|---|
死亡 例数 | 病死率 (%) | 死亡数/ 千人年 | 死亡 例数 | 病死率 (%) | 死亡数/ 千人年 | |||
性别 | ||||||||
男 | 609 | 9.6 | 208 | 34.2 | 35.6 | 31 | 5.1 | 5.3 |
女 | 156 | 10.1 | 25 | 16.0 | 15.8 | 1 | 0.6 | 0.6 |
年龄组(岁) | ||||||||
≤20 | 18 | 8.7 | 1 | 5.6 | 6.4 | 0 | 0.0 | 0.0 |
21~ | 138 | 9.1 | 10 | 7.2 | 7.9 | 0 | 0.0 | 0.0 |
41~ | 257 | 8.9 | 44 | 17.1 | 19.2 | 3 | 1.2 | 1.3 |
≥61 | 352 | 7.2 | 178 | 50.6 | 70.2 | 29 | 8.2 | 11.4 |
治疗史 | ||||||||
初治 | 693 | 10.7 | 201 | 29.0 | 27.1 | 21 | 3.0 | 2.8 |
复治 | 72 | 9.3 | 32 | 44.4 | 47.7 | 11 | 15.3 | 16.5 |
痰涂片结果 | ||||||||
阴性 | 435 | 9.7 | 93 | 21.4 | 22.1 | 14 | 3.2 | 3.3 |
阳性 | 330 | 9.5 | 140 | 42.4 | 44.6 | 18 | 5.5 | 5.9 |
肺空洞 | ||||||||
无 | 618 | 10.8 | 165 | 26.7 | 24.7 | 23 | 3.7 | 3.4 |
有 | 147 | 9.1 | 68 | 46.3 | 50.9 | 9 | 6.1 | 6.7 |
咯血 | ||||||||
无 | 596 | 11.2 | 156 | 26.2 | 23.4 | 16 | 2.7 | 2.4 |
有 | 169 | 9.7 | 77 | 45.6 | 47.1 | 16 | 9.5 | 9.8 |
耐多药结核病 | ||||||||
否 | 760 | 11.6 | 230 | 30.3 | 26.1 | 30 | 3.9 | 3.4 |
是 | 5 | 9.6 | 3 | 60.0 | 62.5 | 2 | 40.0 | 41.7 |
随访 年份 | 全死因死亡 (例) | 因结核死亡 (例) | 全死因病 死率(%) | 因结核病 死率(%) |
---|---|---|---|---|
第1年 | 72 | 20 | 9.4 | 2.6 |
第2年 | 26 | 1 | 3.7 | 0.1 |
第3年 | 25 | 3 | 3.7 | 0.4 |
第4年 | 14 | 2 | 2.2 | 0.3 |
第5年 | 14 | 0 | 2.2 | 0.0 |
第6年 | 15 | 0 | 2.4 | 0.0 |
第7年 | 10 | 0 | 1.7 | 0.0 |
第8年 | 11 | 0 | 1.9 | 0.0 |
第9年 | 8 | 2 | 1.4 | 0.3 |
第10年 | 11 | 1 | 1.9 | 0.2 |
第11年 | 8 | 0 | 1.4 | 0.0 |
第12年 | 8 | 3 | 1.5 | 0.5 |
第13年 | 3 | 0 | 0.6 | 0.0 |
第14年 | 8 | 0 | 1.5 | 0.0 |
合计 | 233 | 32 | 30.5 | 4.2 |
分组 | 观察例数 | 死亡例数 | 风险比(HR)值 | 95%CI值 | P值 |
---|---|---|---|---|---|
性别 | |||||
男 | 609 | 208 | 1 | 1 | |
女 | 156 | 25 | 0.62 | 0.37~0.85 | 0.000 |
年龄组(岁) | |||||
≤20 | 18 | 1 | 1 | 1 | |
21~ | 138 | 10 | 1.21 | 1.03~2.69 | 0.150 |
41~ | 257 | 44 | 1.23 | 1.11~1.39 | 0.023 |
≥61 | 352 | 178 | 1.44 | 1.29~1.57 | 0.010 |
肺空洞 | |||||
无 | 618 | 165 | 1 | 1 | |
有 | 147 | 68 | 2.26 | 1.65~2.92 | 0.001 |
治疗史 | |||||
初治 | 693 | 201 | 1 | 1 | |
复治 | 72 | 32 | 1.83 | 1.52~2.11 | 0.150 |
咯血 | |||||
无 | 596 | 156 | 1 | 1 | |
有 | 169 | 77 | 1.62 | 1.43~1.74 | 0.002 |
分组 | 观察例数 | 死亡例数 | 风险比(HR)值 | 95%CI值 | P值 |
痰涂片结果 | |||||
阴性 | 435 | 93 | 1 | 1 | |
阳性 | 330 | 140 | 1.76 | 1.32~2.24 | 0.000 |
耐多药结核病 | |||||
否 | 760 | 230 | 1 | 1 | |
是 | 5 | 3 | 1.30 | 1.12~1.53 | 0.140 |
并发基础疾病 | |||||
慢性阻塞性肺疾病 | 55 | 28 | 1.77 | 1.18~2.61 | 0.001 |
糖尿病 | 193 | 136 | 3.98 | 3.01~5.07 | 0.023 |
肿瘤 | 64 | 55 | 2.72 | 2.01~3.69 | 0.002 |
分组 | 观察例数 | 死亡例数 | 风险比(HR)值 | 95%CI值 | P值 |
---|---|---|---|---|---|
性别 | |||||
男 | 609 | 31 | 1 | 1 | |
女 | 156 | 1 | 0.42 | 0.12~0.85 | 0.080 |
年龄组(岁) | |||||
≤ 20 | 18 | 0 | 1 | 1 | |
21~ | 138 | 0 | 1.23 | 0.25~0.87 | 0.980 |
41~ | 257 | 3 | 1.52 | 1.01~2.05 | 0.001 |
≥61 | 352 | 29 | 1.98 | 1.05~2.88 | 0.001 |
肺空洞 | |||||
无 | 618 | 23 | 1 | 1 | |
有 | 147 | 9 | 2.85 | 1.33~5.73 | 0.000 |
治疗史 | |||||
初治 | 693 | 21 | 1 | 1 | |
复治 | 72 | 11 | 4.43 | 2.09~9.12 | 0.002 |
咯血 | |||||
无 | 596 | 16 | 1 | 1 | |
有 | 169 | 16 | 3.12 | 1.56~6.25 | 0.000 |
痰涂片 | |||||
阴性 | 435 | 14 | 1 | 1 | |
阳性 | 330 | 18 | 1.70 | 0.85~3.49 | 0.130 |
耐多药结核病 | |||||
否 | 760 | 30 | 1 | 1 | |
是 | 5 | 2 | 12.46 | 2.92~52.99 | 0.001 |
并发基础疾病 | |||||
慢性阻塞性肺疾病 | 55 | 1 | 2.53 | 0.92~3.01 | 0.323 |
糖尿病 | 193 | 25 | 10.12 | 4.35~23.29 | 0.012 |
肿瘤 | 64 | 31 | 3.91 | 2.83~6.23 | 0.192 |
分组 | β值 | s | Wald χ2值 | aHR值 | 95%CI值 | P值 |
---|---|---|---|---|---|---|
性别 | -0.22 | 0.23 | 0.92 | |||
男 | 1 | 1 | ||||
女 | 0.12 | 0.03~0.77 | 0.000 | |||
年龄组(岁) | 0.59 | 1.29 | 0.21 | |||
≤20 | 1 | 1 | ||||
21~ | 1.54 | 1.07~3.82 | 0.530 | |||
41~ | 1.52 | 1.23~1.88 | 0.012 | |||
≥61 | 1.60 | 1.37~1.73 | 0.015 | |||
肺空洞 | 0.73 | 0.15 | 23.49 | |||
无 | 1 | 1 | ||||
有 | 2.12 | 1.57~2.83 | 0.000 | |||
治疗史 | 0.20 | 0.20 | 1.02 | |||
初治 | 1 | 1 | ||||
复治 | 1.83 | 1.53~2.15 | 0.210 | |||
痰涂片结果 | 0.39 | 0.14 | 8.10 | |||
阴性 | 1 | 1 | ||||
阳性 | 1.76 | 1.52~1.91 | 0.001 | |||
耐多药结核病 | 0.443 | 0.60 | 0.54 | |||
否 | 1 | 1 | ||||
是 | 1.73 | 1.21~2.16 | 0.500 | |||
并发基础疾病 | ||||||
慢性阻塞性肺疾病 | 0.29 | 0.21 | 1.90 | 0.72 | 0.46~1.06 | 0.090 |
糖尿病 | 1.01 | 0.15 | 43.16 | 1.35 | 1.26~1.47 | 0.001 |
肿瘤 | 0.29 | 0.18 | 2.60 | 1.78 | 1.48~1.96 | 0.001 |
因素 | β值 | s | Wald χ2值 | aHR值 | 95%CI值 | P值 |
---|---|---|---|---|---|---|
性别 | -2.02 | 1.13 | 3.20 | |||
男 | 1 | 1 | ||||
女 | 0.62 | 0.35~1.84 | 0.069 | |||
年龄组(岁) | -1.99 | 1.17 | 2.92 | |||
≤20 | 1 | 0 | ||||
21~ | 1.12 | 0.02~1.69 | 0.910 | |||
41~ | 1.28 | 0.04~1.72 | 0.960 | |||
≥61 | 1.34 | 0.08~1.85 | 0.026 | |||
肺空洞 | 1.08 | 0.43 | 6.38 | |||
无 | 1 | 1 | ||||
有 | 2.95 | 1.26~6.71 | 0.001 | |||
治疗史 | 0.97 | 0.41 | 5.74 | |||
初治 | 1 | 1 | ||||
复治 | 1.43 | 0.18~1.85 | 0.000 | |||
痰涂片结果 | 0.01 | 0.39 | 0.00 | |||
阴性 | 1 | 1 | ||||
阳性 | 1.17 | 0.48~2.15 | 0.002 | |||
耐多药结核病 | 2.82 | 1.16 | 5.95 | |||
否 | 1 | 1 | ||||
是 | 1.20 | 1.01~1.56 | 0.005 | |||
并发基础疾病 | ||||||
慢性阻塞性肺疾病 | -1.67 | 1.03 | 2.65 | 5.54 | 0.73~40.86 | 0.090 |
糖尿病 | 2.32 | 0.43 | 25.39 | 1.23 | 1.04~1.25 | 0.012 |
肿瘤 | 2.60 | 1.04 | 6.25 | 13.72 | 1.78~95.75 | 0.002 |
[1] | 张曼晖, 刘剑君, 么鸿雁 , 等. 我国肺结核控制目标实现与社会决定因素相关性研究. 中国防痨杂志, 2019,41(1):80-87. |
[2] | World Health Organization. Global tuberculosis report 2019. Geneva:World Health Organization, 2019. |
[3] | 陈卉, 夏愔愔, 张灿有 , 等. 2014—2018年全国学生肺结核疫情变化趋势及特征分析. 中国防痨杂志, 2019,41(6):662-668. |
[4] | World Health Organization. International statistical classification of diseases and related health problems (Tenth revision). 2nd ed. Geneva: World Health Organization, 2007. |
[5] | Aguilar-Company J, Martin MT, Goterris-Bonet L , et al. Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study. Mycoses, 2019,62(9):765-772. |
[6] | Pepper DJ, Marais S, Wilkinson RJ , et al. Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors. BMC Infect Dis, 2010,10:83. |
[7] | 陈红梅, 吴晓光, 马丽萍 , 等. 163例住院老年结核病死亡患者临床特点分析. 中国防痨杂志, 2014,36(1):55-58. |
[8] | 周林, 陈磊, 王倪 , 等. 结核分枝杆菌与艾滋病病毒双重感染患者抗结核治疗期间死亡的影响因素分析. 中国防痨杂志, 2011,33(11):734-738. |
[9] | 顾芳慧, 刘民, 姜世闻 , 等. 北京市两区糖尿病合并肺结核人群流行病学特征分析. 中国预防医学杂志, 2013,14(4):246-250. |
[10] | Low S, Ang LW, Cutter J , et al. Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis, 2009,13(3):328-334. |
[11] | 莫合塔尔·艾麦尔, 吾买尔江·依扎克, 外力·沙塔尔. 新疆阿克苏地区第五轮全球基金结核病/艾滋病双重感染防治项目效果分析. 疾病预防控制通报, 2013,28(6):53-54. |
[12] | Ko PY, Lin SD, Hsieh MC , et al. Diabetes mellitus increased all-cause mortality rate among newly-diagnosed tuberculosis patients in an Asian population: A nationwide population-based study. Diabetes Res Clin Pract, 2017,133:115-123. |
[13] | 赵燕, 孙小璐, 张天华 , 等. 2009—2017年陕西省结核病患者死亡监测分析. 公共卫生与预防医学, 2019,30(2):25-29. |
[14] | Shen X, Deriemer K, Yuan Z , et al. Deaths among tuberculosis cases in Shanghai, China: who is at risk? BMC Infect Dis, 2009,9:95. |
[15] | Lefebvre N, Falzon D . Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J, 2008,31(6):1256-1260. |
[16] | Heuvers ME, Aerts JG, Hegmans JP , et al. History of tuberculosis as an independent prognostic factor for lung cancer survival. Lung Cancer, 2012,76(3):452-456. |
[17] | O’Toole RF, Shukla SD, Walters EH . TB meets COPD: An emerging global co-morbidity in human lung disease. Tuberculosis (Edinb), 2015,95(6):659-663. |
[18] | 谭守勇 . 提高糖尿病并发结核病患者的治疗管理水平. 中国防痨杂志, 2017,39(2):109-110. |
[19] | Fidler MM, Gupta S, Soerjomataram I , et al. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol, 2017,18(12):1579-1589. |
[1] | LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936. |
[2] | DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961. |
[3] | CHEN Yu-mei, LUO Xing-xiong, CHEN Cheng-jiang, SU Ping, WANG Chun-lei.. Analysis of the service capability in city/county tuberculosis designated hospital in Hainan [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 992-993. |
[4] | SUN Hai-yan, LI Shuo, WANG Zhong-dong, REN Zhi-sheng, SONG Song, XUE Bai, ZHANG Hua-qiang, DAI Xiao-qi. Characteristics of the tuberculosis epidemic in schools in Qingdao in 2010—2019 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 994-997. |
[5] | ZHONG Qian-hong, MA Xiao-hui, LIN Zhi-hao, LI Yi, ZHOU Jie, DENG Dong-hua, DENG Ci-xi, LIANG Xiao-min. Evaluation of the application of Foshan Tuberculosis Surveillance and Management Platform in tuberculosis prevention and treatment [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 653-656. |
[6] | BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing. Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724. |
[7] | LIANG Xiao-yan, LIN Mei, LIANG Da-bin, LAN Ru-shu, QIN Hui-fang, YE Jing, HUANG Li-wen. Drug resistance and genotypic characteristics of multidrug-resistant Mycobacterium tuberculosis in Guangxi Zhuang Autonomous Region [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 578-582. |
[8] | LAI Keng, LEI Yu, DU Yu-hua, WU Gui-feng, XIE Wei, SHEN Hong-cheng, ZHONG Zhi-qing, LI Tie-gang. Spatial-temporal analysis on tuberculosis among students in Guangzhou City during 2014-2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 590-596. |
[9] | SHEN Hong-cheng,DU Yu-hua,WU Gui-feng,LEI Yu,LI Tie-gang,LIU Jian-xiong. Epidemiological characteristics of newly reported pulmonary tuberculosis from 2008 to 2018 in Guangzhou [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 322-326. |
[10] | YOU Yuan-yuan,ZHANG Guo-long,CHEN Yu. Analysis of influencing factors of medication adherence among 120 newly diagnosed patients with multi-drug resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(3): 249-254. |
[11] | JIANG Ming-xia, CHAO Xiu-zhen, WANG Zhao-fen, MA Bin-zhong, MA Yong-cheng, WANG Rong, WANG Chao-cai, LI Er-chen, WEI Yu-jia, LI Yong-xue, ZHANG Qi. Drug resistance analysis of 154 Mycobacterium tuberculosis strains in southern Qinghai [J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1289-1293. |
[12] | MA Jin-bao, MA Ting-ting, REN Fei, YANG Han, TAN Gan-wen. Analysis on risk factors associated with false negative results of interferon-gamma release assay in active tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1299-1304. |
[13] | LYU He, WANG Zheng, WANG Ting, YAN Ya-geng, DONG Feng-li, YANG Xiao-wei, ZHANG Lin, GUO Xiao-wei, WANG Hong-mei, XU Huan. Analysis of status and risk of nutrition of inactive tuberculosis patients complicated with chronic obstructive pulmonary disease [J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1310-1312. |
[14] | YAO Jing, GU Kai-kan, LI Zhi-hong, HAN Zhi-ying, ZHANG Huai-qing. A comparative analysis of the epidemic characteristics of tuberculosis in elderly and non-elderly in Jing’an District, Shanghai from 2014 to 2019 [J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1323-1328. |
[15] | LI Meng, LU Li-ping, JIANG Qi, HONG Jian-jun, GAO Qian, YANG Chong-guang, GUO Xiao-qin. Analysis of the types and expense of therapeutic drugs for pulmonary tuberculosis in Songjiang District of Shanghai [J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1329-1332. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||